were: Patients with aortic or cerebrovascular disease (n = 4), lung, renal or hepatic dysfunction (n = 5), pulmonary artery hypertension (n = 2), usage of antiplatelet drugs or corticoids before surgery (n = 10), a history of acute myocardial infarction (n = 1), and incomplete recordings (n = 7). Patients with surgical re-exploration for hemostasis (n = 2) were also excluded from analysis. Ultimately, 208 patients were involved. Data obtained in the study included patient characteristics, demographic variables, perioperative clinical variables, and postoperative outcomes. Data were collected by a student who was blinded to the study design.
Cardiac surgical procedure and protocol
Anesthesia was induced with midazolam, sufentanil and rocuronium, and maintained with an infusion of sufentanil, inhalation of sevoflurane (1-2% end-tidal concentration), and intermittent cis-atracurium. CPB was established in a standard procedure. The membrane oxygenator (Medtronic, Minneapolis, MN, USA) was primed with 500 ml crystalloid solution and 1000 ml succinylated gelatine injection (Braun Pharmaceutical Co Ltd., Shenyang, China). The flow rate was set at 2.0-2.5 L −1 ·min −1 ·m −2 during CPB. The body temperature was moderately cooled to 32°C. The heart was arrested by cold blood cardioplegia. The hematocrit was maintained above 20% and the mean arterial pressure was maintained between 50 and 75 mmHg during CPB. System anticoagulation was achieved with heparin 375 U/kg initially and additional intermittent injection to maintain the activated clotting time above 480 s during CPB. After weaning from CPB, heparin was neutralized with protamine in a 1:1 ratio to the initial dose of heparin.
Intervention
The patients were divided into two groups based on administration of UTI (Techpool Bio-pharma Co Ltd., Guangdong, China, Group U) or not (control group, Group C). The use of UTI was based on the assessment of attending anesthesiologists on patient's condition. According to the recommendation, [9] which was believed to be the best way to protect organs from injury, patients in Group U received a total dose of UTI of 10,000-20,000 U/kg, half of which were administered before surgical incision, and the rest was primed into CPB.
Outcomes
The primary outcomes were composite serious adverse outcomes in total, including death and emerging organs dysfunction in hospital. The diagnostic criteria of ALI and acute respiratory distress syndrome (ARDS) were based on the American-European Consensus Conference criteria. [10] Renal dysfunction was defined as an increase in postoperative serum creatinine over 0.3 mg/dl (26.4 μmol/L) or an increase over preoperative baseline levels of at least 150-200%. [11] The systems for staging and classifying acute kidney injury (AKI) were referred to RIFLE (Risk, Injury, Failure, Loss, and End-stage kidney disease) criteria. [11] The second outcomes were other adverse outcome in total, including AKI required hemodialysis, infection, re-incubation, and tracheotomy in hospital. The mechanical ventilation time, and the length of Intensive Care Unit (ICU) and hospital stays were also recorded. Based on the ICU protocol, patients were extubated if they met the following criteria: Recovered neurologic functions, stable hemodynamics, chest drainage <50 ml/h for 2 consecutive hours, and normal respiration and oxygenation function after mechanical ventilation being weaned off. Patients were discharged from ICU according to the surgeon.
To observe the inhibition of UTI on inflammation, plasma levels of tumor necrosis factor-α (TNF-α, R&D, Minneapolis, MN, USA) and Neutrophil Elastase (NE, R&D), which were determined by ELISA before CPB, 4 h and 20 h in ICU, were also recorded.
Statistical analysis
Data were collected by a researcher blinded to the study design and analyzed using SAS 9.13 (SAS Institute, Cary, NC, USA) with a significance threshold of P < 0.05. Categorical variables were expressed as frequencies and percentages, and continuous variables were reported as means and standard deviations or median (interquartile range) for normal or abnormal distribution. Categorical variables were compared between groups using Fisher's exact test; normally distributed continuous variables, using unpaired Student's t-test; and nonnormally distributed continuous variables, using the Mann-Whitney U-test. One-way analysis of variance (ANOVA) and Dunnett's or Tukey's tests were used to compare values at different time points within the same group.
Risk of outcomes in terms of odds ratios and 95% confidence intervals (CIs) was estimated using unadjusted data or data for which baseline differences in adverse events were adjusted using multivariable logistic regression. In a second approach, risk was estimated using data adjusted for differences in all of the baseline variables using propensity scoring. The propensity model had a C statistic of 0.89. In a third approach, data were adjusted by applying mixed-effect models to continuous outcome variables, which were reported as differences in least-squares means and 95% CIs.
results

Patients characteristics
There were no statistical differences of patients' characteristics between two groups [ Table 1 ]. Double valves replacement and tricuspid valve plasty or radio frequency current ablation (MAZE operation) were more in the Group U (P < 0.002) than Group C. CPB time and the aortic cross-clamp time tended to be longer, and corticoids were more likely to be used in Group U, but without statistical differences between groups [ Table 1 ].
Urinary trypsin inhibitor did not improve outcomes after cardiac surgery
As shown in Table 2 , the serious adverse complications in total were similar between two groups (P = 0.967). The
Urinary trypsin inhibitor and inflammatory response
Both leukocyte and neutrophil counts increased, while platelet count decreased after surgery in both groups; however, there was no difference between two groups [P > 0.05, Table 5 ].
Both plasma TNF-α and NE profiles were similar in two groups [ Table 5 ]. Plasma levels of TNF-α and NE significantly increased at 4 h in ICU, and TNF-α, but not NE, reduced to the baseline at 20 h after surgery.
dIscussIon
Cardiac surgery under CPB is known to cause more severe systemic inflammatory responses than other surgeries. [1] [2] [3] [4] [5] TNF-α, as an effective activator for leukocytes such as neutrophils, [12] significantly increased after cardiac surgery. [7, 8] As a result, neutrophils would be trapped in tissue to release proteases, such as NE, a cytotoxic enzyme to break down collagen and elastin of the matrix, [9, 13] and induce capillary leakage. In the present study, we found NE peaked at 4 h, and remained higher at 20 h after surgery. ALI and ARDS occurred in 15.4% and 8.7%, while AKI was found in 6.7% patients in our study, which were similar with previous reports. [14, 15] Thus, it was widely used in Asia to inhibit the inflammatory response induced by cardiac surgery. [7, 8] Our study confirmed that it was used in about one-third patients undergoing heart surgery. UTI was reported to protect heart, liver, kidney, and lung against inflammatory response.
[ [16] [17] [18] [19] This was similar to other adverse complications were also similar (P > 0.05). Furthermore, there was no difference in the duration of postoperative mechanical ventilation, the length of ICU and hospital stays between two groups [ Table 2 , P > 0.05].
Logistic regression analysis was used to identify the impact of UTI on outcomes. There was no statistical difference before and after adjusted by multivariable logistic regression analysis with regard to the adverse complications in total [ Table 3 ], and utilization of medical resources, including duration of mechanical ventilation, length of ICU and hospital stays after surgery between two groups (data not shown), even after the propensity score was incorporated into this model [ Table 3 ].
We also determined if UTI improved the biochemical index after cardiac surgery. As shown in Table 4 , PaO 2 /FiO 2 decreased, while blood urea nitrogen increased significantly at 20 h after surgery (P < 0.05), suggesting ALI and AKI occurred after surgery. However, there was no statistical difference with regard to PaO 2 /FiO 2 and blood urea nitrogen levels between two groups before and after surgery [ Table 4 ]. that corticoids were apt to be administrated to the children with higher risk adjustment for congenital heart surgery categories. [20] In the present study, we found that UTI neither reduced the incidence of acute organ injuries nor shortened the mechanical ventilation time, the length of ICU and hospital stay. To remove the impact of selection bias and baseline confounders, the measured variables were adjusted by multiple logistic regression and propensity score, and the outcomes were still similar between two groups. Therefore, our findings do not support the concept that UTI improves the outcomes after cardiac surgery.
The impact of anti-inflammatory interventions on clinical outcomes was controversial. Corticosteroids are commonly used to reduce postoperative inflammation induced by CPB. Although numerous studies with small sample size have shown that they can reduce levels of certain inflammatory factors, a meta-analysis reported that corticoids could not reduce mortality nor improve cardiac or pulmonary complications after cardiac surgery. [21] Pasquali et al. also found no benefit associated with corticosteroids for children undergoing congenital heart surgery.
[20] Just 2 years ago, a multicenter, randomized, double-blinded and placebo-controlled trial reported that dexamethasone did not reduce the incidences of major adverse events [22] and postpericardiotomy syndrome.
[23] On the contrary, corticosteroids might be associated with significantly longer postoperative ICU stays and more severe postoperative infection. [20] Recently, a meta-analysis has shown that UTI reduced the inflammatory cytokines, but not hospital mortality or morbidity. [24] Park et al. also found that UTI had not significant impact on major organs dysfunction, systemic inflammatory reaction and other postoperative profiles. [25] Our results proved again that the effect of UTI on inflammatory response could not be translated into a clinical benefit. The complex, multifaceted nature of inflammatory response induced by CPB requires re-evaluation of the role of UTI in cardiac surgery.
On the other hand, the effect of UTI on outcome might be weakened by the strategy of administration. [26] The half-life of UTI is only about 40 min in healthy adults, [27] while the duration of CPB is usually greater than 40 min, and both activation of leukocytes and release of proinflammatory factors peak at 4-6 h after surgery. [7, 28] Furthermore, in clinical practice, UTI is administered by bolus injection, rather than continuous infusion. [13] This may explain why there was no difference of proinflammatory factors between the two groups in our study. It indicates a possibility that a longer period of UTI infusion may provide organ protection function.
This study was limited by a retrospective, nonrandomized study. The design induced the surgical procedure was more complex in Group U than Group C. Furthermore, this study was performed in a single center. Therefore, a randomized control trial with larger sample size is warranted.
In conclusion, our data do not show that UTI can improve the outcome or attenuate the inflammatory response after cardiac surgery. Thus, a suspended question has been put forward that the comparative trials powered for important clinical end points are needed before routine administration of UTI.
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